Last week in Washington, D.C., we celebrated 40 brilliant high school innovators and awarded over $1.8 million to support their groundbreaking solutions to today’s biggest challenges. 🌎 The Regeneron Science Talent Search, a program of Society for Science, is America’s longest-running and most prestigious science and math competition. For more than 80 years, it has elevated talented young scientists whose discoveries have the potential to improve our world. Take a look inside this year’s #RegeneronSTS and the inspiring moments shaping the future of science!
About us
At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media.
- Website
-
http://www.regeneron.com
External link for Regeneron
- Industry
- Biotechnology
- Company size
- 10,001+ employees
- Headquarters
- Tarrytown, New York
- Type
- Public Company
Locations
Employees at Regeneron
Updates
-
We’re always researching the under recognized diseases – many of which predominantly affect women. While conditions like endometriosis, which impacts over 6 million women in the U.S., remain overlooked, even widely recognized diseases like breast cancer still face research gaps. Read how Regeneron Genetics Center (RGC) is helping pave the way for more representative research in our piece with Custom Content from WSJ. https://bit.ly/41Z6xkD
-
Congratulations to the 2025 #RegeneronSTS top winners and all the exceptional finalists! 🎉 🏅First Place: Matteo Paz 🏅Second Place: Ava Grace Cummings 🏅Third Place: Owen Jianwen Zhang Regeneron Science Talent Search, a program of Society for Science, is America’s oldest and most distinguished science and math competition for high school students — empowering the next generation of innovators tackling society’s biggest challenges. Tap through to read more about the innovative research from these brilliant, young STEM leaders. https://bit.ly/41LEZOl
-
On #InternationalWomensDay, we bring focus to women’s health research and the importance of representation in clinical trials. Here, this takes shape in a few different ways that are important to scientific innovation. 👩💻Starting last year, our WISER (Women in Industry, Science, and Engineering at Regeneron) employee resource group hosted a series of seminars highlighting unique diseases and health challenges faced by women. These sessions help our colleagues connect their work in our labs and offices to unmet needs of patients. This year WISER will continue to host sessions that dive into these under-researched areas. 🔬In our Regeneron Genetics Center labs, our exploration of human genetics – especially for diseases that are under-researched – leads to potentially transformative discoveries in diseases that impact women such as #endometriosis, and we're collaborating with Rutgers in a study of the genetics of #breastcancer. 📚We're committed to bringing it forward to the next generation of scientists. We support a variety of #STEM programs that help young women scientists globally through education, mentorship and more. 🩺 Being able to achieve the extraordinary for patients starts with being supported in your own life. Our benefits cover many aspects of colleagues’ wellbeing, including journeys to parenthood, paid parental leave and menopause assistance as well as personalized coaching and support to colleagues. Our investments in these areas reflect our desire to advance and support our talent, fuel our innovation pipeline and deliver more for patients.
-
It has come to our attention that there have been recent attempts to impersonate Regeneron or its recruiters as part of a hiring scam. Safety and security are our priorities, so please note that all Regeneron recruiter email addresses end with @regeneron.com and will not ask for sensitive personal information. If you receive any suspicious communication, please verify its authenticity by reaching out to us: https://lnkd.in/efiFcp2a
-
The 2025 Regeneron Science Talent Search Finals Week has begun! This week, the top 40 finalists are in Washington, D.C., presenting groundbreaking research and competing for over $1.8 million in awards. #RegeneronSTS, a program of Society for Science, celebrates young innovators using their STEM talent and leadership to push the boundaries of discovery and tackle today’s biggest challenges. Follow along as they share their projects with the public, visit iconic D.C. sites and take the stage at the awards ceremony, where we’ll honor the next generation of scientific leaders! Learn more about this year’s finalists: https://bit.ly/4kpn6xr
-
Today, in recognition of #WorldObesityDay, Regeneron continues to work on innovative solutions to help reduce the rates of obesity. Recent advancements in the treatment of obesity have made significant strides in helping people lose weight—but it often comes at a cost: a loss of muscle mass, which can have a negative impact on metabolic health and overall physical fitness. Our years of research and subsequent scientific discoveries around muscle and metabolism have led us to focus our research efforts on a muscle preservation approach with a goal to help preserve or even grow muscle during periods of caloric restriction. With these innovative approaches, Regeneron is striving to shift the conversation around weight loss so it’s not just about quantity, but quality, too.
-
What we’re reading this weekend: The Science of Questioning Everything. As part of a partnership with Custom Content from WSJ, our President and CSO George Yancopoulos sat down to share how his need to question everything grew into a philosophy that drives Regeneron today. Read more about George’s principles for radical innovation here:
-
We’re harnessing the potential of genetic medicines research and cutting-edge technologies to drive progress for people living with genetic forms of hearing loss. Learn more about our approach to advance the field of audiology and follow along as we showcase our latest research at #ARO2025 Annual MidWinter Meeting: https://lnkd.in/eYq7GDp6
-
Every year on #ValentinesDay, we share a love note to science. 💕🔬This year, we asked our global colleagues to share in the love, and they got creative – submitting poetry honoring the important work we do here. Check out one by our colleague Louise O. from Regeneron Ireland! 💌
Affiliated pages
Similar pages
Browse jobs
Stock
REGN
NASDAQ
20 minutes delay
$664.96
-13.46 (-1.984%)
- Open
- 678
- Low
- 664.3
- High
- 678.27
Data from Refinitiv
See more info on